Open Access. Powered by Scholars. Published by Universities.®

Digital Commons Network™

Open Access. Powered by Scholars. Published by Universities.®

Discipline
Institution
Keyword
Publication Year
Publication
Publication Type
File Type

Articles 568351 - 568380 of 5159159

Full-Text Articles in Entire DC Network

Mr. Willie Louis Mincey "Big Lou" Feb 2023

Mr. Willie Louis Mincey "Big Lou"

African American Funeral Programs

Mr_Willie_Louis_Mincey--Big--Lou--.pdf - Funeral program for Willie Mincey


Nathan Lionel Hendley Feb 2023

Nathan Lionel Hendley

African American Funeral Programs

Nathan_Lionel_Hendley.pdf - Funeral program for Nathan Hendley


Impact Of Timing To Initiate Adjuvant Therapy On Survival Of Elderly Glioblastoma Patients Using The Seer-Medicare And National Cancer Databases, Ping Zhu, Xianglin L Du, Lu-Yu Hwang, David Lairson, Ruosha Li, Yoshua Esquenazi, Jay-Jiguang Zhu Feb 2023

Impact Of Timing To Initiate Adjuvant Therapy On Survival Of Elderly Glioblastoma Patients Using The Seer-Medicare And National Cancer Databases, Ping Zhu, Xianglin L Du, Lu-Yu Hwang, David Lairson, Ruosha Li, Yoshua Esquenazi, Jay-Jiguang Zhu

Faculty, Staff and Student Publications

The optimal time to initiate adjuvant therapy (AT) in elderly patients with glioblastoma (GBM) remains unclear. We investigated the impact of timing to start AT on overall survival (OS) using two national-scale datasets covering elderly GBM populations in the United States. A total of 3159 and 8161 eligible elderly GBM patients were derived from the Surveillance, Epidemiology and End Results (SEER)-Medicare linked dataset (2004-2013) and the National Cancer Database (NCDB) (2004-2014), respectively. The intervals in days from the diagnosis to the initiation of AT were categorized based on two scenarios: Scenario I (quartiles), ≤ 15, 16-26, 27-37, and ≥ 38 …


Dft-Aided Machine Learning-Based Discovery Of Magnetism In Fe-Based Bimetallic Chalcogenides, Dharmendra Pant, Suresh Pokharel, Subhasish Mandal, Dukka Kc, Ranjit Pati Feb 2023

Dft-Aided Machine Learning-Based Discovery Of Magnetism In Fe-Based Bimetallic Chalcogenides, Dharmendra Pant, Suresh Pokharel, Subhasish Mandal, Dukka Kc, Ranjit Pati

Michigan Tech Publications, Part 1

With the technological advancement in recent years and the widespread use of magnetism in every sector of the current technology, a search for a low-cost magnetic material has been more important than ever. The discovery of magnetism in alternate materials such as metal chalcogenides with abundant atomic constituents would be a milestone in such a scenario. However, considering the multitude of possible chalcogenide configurations, predictive computational modeling or experimental synthesis is an open challenge. Here, we recourse to a stacked generalization machine learning model to predict magnetic moment (µB) in hexagonal Fe-based bimetallic chalcogenides, FexAyB; A represents Ni, Co, Cr, …


Ceron Anthony Lee Feb 2023

Ceron Anthony Lee

African American Funeral Programs

No abstract provided.


Recent Advances In Psychopharmacology: From Bench To Bedside Novel Trends In Schizophrenia, Asim A Shah, Syed Z Iqbal Feb 2023

Recent Advances In Psychopharmacology: From Bench To Bedside Novel Trends In Schizophrenia, Asim A Shah, Syed Z Iqbal

Faculty, Staff and Students Publications

Research in the field of psychopharmacology is ongoing to develop novel compounds which can revolutionize the treatment of psychiatric disorders. The concept of bench-to-bedside is a tedious process, transforming the initial research performed in the laboratories into novel treatment options. Schizophrenia (SCZ) is a chronic psychiatric illness with significant morbidity and mortality. SCZ not only presents with psychotic symptoms including hallucinations and delusions but also with negative and cognitive symptoms. The negative symptoms include the diminished ability to express emotions, loss of pleasure, and motivation with minimal social interactions. Conventional antipsychotics primarily target positive symptoms with minimal therapeutic benefits for …


Membrane Phospholipids Control Gating Of The Mechanosensitive Potassium Leak Channel Trek1, Philipp A M Schmidpeter, John T Petroff 2nd, Leila Khajoueinejad, Aboubacar Wague, Cheryl Frankfater, Wayland W L Cheng, Crina M Nimigean, Paul M Riegelhaupt Feb 2023

Membrane Phospholipids Control Gating Of The Mechanosensitive Potassium Leak Channel Trek1, Philipp A M Schmidpeter, John T Petroff 2nd, Leila Khajoueinejad, Aboubacar Wague, Cheryl Frankfater, Wayland W L Cheng, Crina M Nimigean, Paul M Riegelhaupt

2020-Current year OA Pubs

Tandem pore domain (K2P) potassium channels modulate resting membrane potentials and shape cellular excitability. For the mechanosensitive subfamily of K2Ps, the composition of phospholipids within the bilayer strongly influences channel activity. To examine the molecular details of K2P lipid modulation, we solved cryo-EM structures of the TREK1 K2P channel bound to either the anionic lipid phosphatidic acid (PA) or the zwitterionic lipid phosphatidylethanolamine (PE). At the extracellular face of TREK1, a PA lipid inserts its hydrocarbon tail into a pocket behind the selectivity filter, causing a structural rearrangement that recapitulates mutations and pharmacology known to activate TREK1. At the cytoplasmic …


Utrf Policy 2008-1 Feb 2023

Utrf Policy 2008-1

Transactional Matter Files

No abstract provided.


Tax Policy Center State Unemployment Rate Feb 2023

Tax Policy Center State Unemployment Rate

Transactional Matter Files

No abstract provided.


Side Agreement 12-1-10 Feb 2023

Side Agreement 12-1-10

Transactional Matter Files

No abstract provided.


Officer's Certificate Of Icare Llc 12-1-10 Feb 2023

Officer's Certificate Of Icare Llc 12-1-10

Transactional Matter Files

No abstract provided.


Master Consulting Services Agreement 12-1-10 Feb 2023

Master Consulting Services Agreement 12-1-10

Transactional Matter Files

No abstract provided.


Lowe - Ucc.Financ.Stmt.-11.23.09-Jao Feb 2023

Lowe - Ucc.Financ.Stmt.-11.23.09-Jao

Transactional Matter Files

No abstract provided.


Intellectual Property License Utrf- Icare 12-1-10 Feb 2023

Intellectual Property License Utrf- Icare 12-1-10

Transactional Matter Files

No abstract provided.


Intellectual Property License Icare- Wolters 12-1-10 Feb 2023

Intellectual Property License Icare- Wolters 12-1-10

Transactional Matter Files

No abstract provided.


Correspondence, Articles Of Organization, Check 10-1-09 Feb 2023

Correspondence, Articles Of Organization, Check 10-1-09

Transactional Matter Files

No abstract provided.


Correspondence Re Letter Of Intent Icare 9-7-10 Feb 2023

Correspondence Re Letter Of Intent Icare 9-7-10

Transactional Matter Files

No abstract provided.


Correspondence Re Letter Of Intent Icare 6-21-10 Feb 2023

Correspondence Re Letter Of Intent Icare 6-21-10

Transactional Matter Files

No abstract provided.


Correspondence Re Letter Of Intent Icare 5-27-10 Feb 2023

Correspondence Re Letter Of Intent Icare 5-27-10

Transactional Matter Files

No abstract provided.


Correspondence Matt Bell Re Venture Development Assistance 1-5-10 Feb 2023

Correspondence Matt Bell Re Venture Development Assistance 1-5-10

Transactional Matter Files

No abstract provided.


Apa - Assumed & Excluded Liabilities Feb 2023

Apa - Assumed & Excluded Liabilities

Transactional Matter Files

No abstract provided.


Amended & Restated Basic Agreement 11-23-10 Feb 2023

Amended & Restated Basic Agreement 11-23-10

Transactional Matter Files

No abstract provided.


Schedule 6.3(B) Feb 2023

Schedule 6.3(B)

Transactional Matter Files

No abstract provided.


Schedule 4.11(A) Feb 2023

Schedule 4.11(A)

Transactional Matter Files

No abstract provided.


Schedule 4.10(A)(I) Feb 2023

Schedule 4.10(A)(I)

Transactional Matter Files

No abstract provided.


Schedule 2.3(I) Feb 2023

Schedule 2.3(I)

Transactional Matter Files

No abstract provided.


Schedule 2.3(H) Feb 2023

Schedule 2.3(H)

Transactional Matter Files

No abstract provided.


Schedule 2.3(A) Feb 2023

Schedule 2.3(A)

Transactional Matter Files

No abstract provided.


Schedule 2.2(B) Feb 2023

Schedule 2.2(B)

Transactional Matter Files

No abstract provided.


Schedule 2.1(B)(Xi) Feb 2023

Schedule 2.1(B)(Xi)

Transactional Matter Files

No abstract provided.